The effect of cardiac glycosides on auricular flutter produced by the method of Rosenblueth and Garcia Ramos is studied. In the denervated heart these drugs produce an increase in the effective refractory period, a decrease in conduction velocity and excitability. The flutter is reverted to a sinus rhythm because of the increase in the effective refractory period. In the innervated heart these glycosides can change the auricular flutter to auricular fibrillation. This change is mediated through the vagus since atropine or cutting the vagi promptly reverts the fibrillation to a sinus lhythmii. The change from auricular flutter to fibrillation ws-as never observed in vagotomized dogs. RSOSENBLUETH and Garcia Ramosl-' have developed a method for the production of a long lasting, self-perpetuating type of auricular flutter in anesthetized dogs. Evidence has been presented by these investigators which indicates that this phenomenon is due to a circus movement traveling around a central obstacle.'-'
The action of cardiac glycosides on the heart has been extensively studied; little is known, however, concerning the action of these drugs in auricular flutter. One reason for this has been the lack of reliable methods for producing this condition in experimental animals. With the appearance of the method of Rosenblueth and Garcia RIamos it wvas thought possible to elucidate some of the complex events which occur in fluttter as a result of the administration of cardiac glycosides. In the present study the effects of three pure glycosides, g-strophanthin, digitoxin and lanatoside C( have been studied on to the decrease in auricular rate. The pulse rate gradually increased until the pulse deficit disappeared. Following reversion to sinus rhythm attempts to restart the flutter by repeated auricular stimulation were unsuccessful (figure 1). In general, qualitatively similar results were obtained with digitoxin, lanatoside C and g-strophanthin (table 1) . Control injections of ethyl alcohol in a dosage of 0.2 to 0.3 cc. per Kg. did not appreciably or consistently change the auricular or ventricular rate during auricular flutter.
There was no correlation of the percentage reduction in auricular flutter rate at the time of reversion to sinus rhythm with the control rate of flutter. In some of the experiments there was a change of only 8 per cent and in another a 39 per cent change in rate was necessary before reversion to sinus rhythm occurred. Table 1 summarizes the data obtained in the 32 experiments considered in this report.
Quantitative differences between the various glycosides were observed. The dosage necessary for reversion to a sinus rhythm was lowest for g-strophanthin, highest for digitoxin and intermediate for lanatoside C (table 1). The same sequence of effectiveness has been observed regarding the toxicity or therapeutic efficacy of these glycosides.4 When the dosage is expressed toxin is the slowest. This sequence in speed of action has been demonstrated for other pharmacologic effects of these glycosides.6
Determination of the Mlaximum Rate. The method employed is an adaptation of the one employed by Dawes in the isolated auricle of the rabbit.7 In our experiments the maximum rate of stimulation which the in situ auricle will follows was determined. The heart was denervated and recording and stimulating clips were applied to the auricle. The maximum rate was determined at progressively increasing voltages. Following two to three control observations the glycoside was administered and 15 to 90 minutes later the maximum rate was In 6 dogs auricular flutter was started in the intact (without crush) innervated auricle. All of these animals weighed over 16.5 Kg. and the heart weights exceeded 130 grams. Following control periods lasting 40 to 60 minutes lanatoside C in a dose of 0.06 to 0.1 mg. per Kg. was given by vein. In five out of six of these experiments the injection of lanatoside resulted in a primary reduction in auricular rate which was then followed by a sudden increase in rate (figs. 4 and 5). This increase in rate in all instances exceeded 800 beats per minute. Electrograms indicated marked irregularity in both the rate and configuration of those impulses. spontaneously to a normal rhythm. Attempts to restart the auricular flutter by repeated stimulation were unsuccessful. In the four other D)IsCUSSlON MIethodical differences in the production of auriculai. flutter may conceivably result in different pharmacologic responses to various drugs. The method used in the present study was the one studied extensively by 1Rosenblueth and Garcia Ramos.-1 These investigators have presented good evidence that this type of flutter is a circus movement. Prinzmetal and associates" and Sherf and Terranova9 have studied aconite-produced auricular flutter and fibrillation and these investigators have presented c(onv inring evidence that a(eonite-indticed flutter and fibrillation are dcue to a rapidly discharging focus. The essential facts presented by Rosenblueth and Garcia Ramos have been confirmed in this laboratory. It period which is the time before the muscle will again transmit a propagated impulse to any distance.?3 The lengthening of the effective refractory period by antifibrillating agents is thus of importance in the reversion of flutter to a normal sinus rhythm by these drugs. In our experiments maximum rate was decreased about 15 to 25 per cent by amounts of cardiac glycosides which restored a sinus rhythm in auricular flutter. The decrease in ventricular rate always followed the administration of the glycosides. In most instances the decrease in ventricular rate was proportional to the decrease in auricular rate. With quinidine and procaine a decrease in auricular flutter rate may be accompanied by a relative or absolute increase in ventricular rate.'4' ' This is probably due to the fact that at slower auricular rates the ratio of ventricular to auricular beats is increased.'6 With the cardiac glycosides studied there was always an absolute change but no relative change in ventricular rate. This difference between cardiac glycosides and quinidine may be due to the well known effects of the former compounds on auriculoventricular conduction.
In the innervated heart the cardiac glycosides studied may change the flutter to auricular fibrillation. This has been observed only in dogs weighing more than 16 Kg. and where flutter could be initiated without a crush injury. In all the experiments so far observed auricular fibrillation produced by cardiac glycosides could be abruptly stopped by vagal cutting or blockade with atropine. The change of flutter to fibrillation can be produced by electrical or pharmacologic stimulation of the vagus. The conclusion to be drawn is that at least in the dog a change from flutter to fibrillation is mediated through the vagus. The well known vagal effects of the cardiac glycosides may conceivably be the cause of this change. Lewis 
SUMMARY
The action of g-strophanthin, digitoxin and lanatoside C was studied on auricular flutter produced in dogs by the method of Rosenblueth and Garcia Ramos.
In the denervated heart these glycosides produce a decrease in auricular flutter rate and in sufficient amounts revert the flutter to a normal sinus rhythm. The decrease in auricular flutter rate is probably due to a decrease in auricular conduction velocity. A second effect of these glycosides that has been demonstrated is a decrease in the maximum rate the auricle will follow. This decrease in maximum rate is probably due to an increase in the effective refractory period and is a possible cause for the reversion to sinus rhythm produced by these glycosides.
In the innervated heart the observation has been made that lanatoside C will change auricular flutter to fibrillation. This change is mediated through the vagus nerve since atropine or vagal cutting will revert the auricular fibrillation to a sinus rhythm.
It is concluded that in the dog the direct action of cardiac glycosides on the auricle tend to increase the refractoriness and decrease the conduction velocity of auricular muscle while the reflex vagal action of these glycosides tends to decrease the refractory period and increase the conduction velocity in this tissue. The net effects on the innervated fluttering auricle are thus dependent on the magnitude of either one of these actions.
